Paper Title
Drug Use Evaluation of Ceftriaxone in Nifas silk lafto w-01 Health Center
Article Identifiers
: Authors
Keywords
antimicrobials, ceftriaxone, drug use evaluation; DUE, Ethiopia
Abstract
Background Ceftriaxone is one of the most commonly used antibiotics due to its availability, wide spectrum of activity and low toxicity. However, irrational use of ceftriaxone is one of the current issues in most countries, especially developing ones. Objective The aim of this study was to evaluate ceftriaxone utilization in INPATINT wards of Nifas silk lafto w-01 HC in Ethiopia. Methods An institution-based retrospective cross-sectional study was conducted on randomly selected 1,0 patients who were admitted to NSLW01HC from TIRE 2016 to MAGBATE 2016. A structured data abstraction format was used to collect data from patients’ Card patient. Medscape® drug interaction checker was used to identify significant drug–drug interactions, and national and international guidelines ,STG ,EPHCCG ,were used to evaluate the appropriateness of ceftriaxone use. The data were analyzed by using SPSS version 20.0. Results Among the 103 patients enrolled, ceftriaxone was utilized by 53 (51.7%) patients, and these patients were considered for evaluation of appropriateness and subsequent analysis. Among 53patients, ceftriaxone was used for empiric therapy in 47 (60.2%) patients; of which, were for prophylaxis 10 (99.2%) ,In the majority of the patients, the dose of ceftriaxone was 1g/day 472 (78.6%) and for a duration of 2–7 days 409 (68.1%). Inappropriate use of ceftriaxone was observed among 237 (39.4%) patients with regard to indication, dose/frequency and duration. About half (49.3%) of the deviation from the guidelines was observed from surgical and gynecologic/obstetrics wards. Among the co-prescribed medications with ceftriaxone, ringer lactate, Vitamine B COMPLEX and were found to have a significant drug–drug interaction. Conclusion This study revealed that inappropriate use of ceftriaxone was high in NSLW01HC . This may increase the emergence of resistant pathogens which may lead to treatment failure and increase cost of therapy. Therefore, adherence to current evidence-based guidelines is recommended.
Downloads
How To Cite (APA)
firaol tilahin alamu, mahlet abebe , & getnet derero (June-2024). Drug Use Evaluation of Ceftriaxone in Nifas silk lafto w-01 Health Center. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(6), c138-c147. https://ijnrd.org/papers/IJNRD2406214.pdf
Issue
Volume 9 Issue 6, June-2024
Pages : c138-c147
Other Publication Details
Paper Reg. ID: IJNRD_222001
Published Paper Id: IJNRD2406214
Downloads: 000122006
Research Area: Pharmacy
Author Type: Foreign Author
Country: addisa ababa, ethiopa, Ethiopia
Published Paper PDF: https://ijnrd.org/papers/IJNRD2406214.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2406214
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Copyright & License
© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.
You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.
IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.
Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.
For more details, refer to the official notice: UGC Public Notice
Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: December 2025
Current Issue: Volume 10 | Issue 12 | December 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Dec-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
Approval, Licenses and Indexing: More Details
